NASDAQ

Halozyme Therapeutics, Inc. (HALO)

♥ 1058 Thanks from members

Live price chart, market sentiment, and community perspectives for Halozyme Therapeutics, Inc. (NASDAQ: HALO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Gregory I. FrostLeadership: Helen Torley (CEO)Leadership: Greg Turnbull (CFO)Holder: FMR LLCHolder: BlackRock IncHolder: Vanguard Group IncENHANZE Drug Delivery TechnologyHYLENEX humanPartnered Subcutaneous Biologics#HALO#Halozyme Therapeutics#NASDAQ HALO#ENHANZE#Biotech Drug Delivery